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1.22, 1.00, 0.90, 0.85, 0.83, 0.90, 1.09, 1.54, and 3.21.
CONCLUSIONS: The five MH5 items fit the Rasch
model very well. Classic summative scoring tends to com-
press the measurement scale at its extremities, by assign-
ing scores that are too low at the high end, and too high
at the low end. Rasch scoring may render MH5 more
sensitive to changes among well populations and among
the very sick.
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OBJECTIVES: In 1997, the Dutch College of General
Practitioners in the Netherlands issued guidelines which
recommend a wait-and-see policy for patients with lateral
epicondylitis. However, these guidelines are not evidence-
based. This paper presents the results of an economic
evaluation in conjunction with a randomized controlled
trial to evaluate the effects of three interventions for pa-
tients with lateral epicondylitis. METHODS: 185 Pa-
tients with pain at the lateral side of the elbow were ran-
domized to one of three interventions: a wait-and-see
policy (n  59), corticosteroid injections (n  62) or
physiotherapy (n  64). Clinical outcomes included gen-
eral improvement, pain during the day, elbow disability
and quality of life (EuroQol). Direct and indirect costs
were measured by means of cost diaries over a period of
12 months. Differences in mean costs between groups
were evaluated by applying non-parametric bootstrap
techniques. RESULTS: After 12 months, the success rate
in the physiotherapy group (91%) was significantly
higher than in the injection group (69%), but only
slightly higher than in the wait-and-see group (83%).
With regard to pain during the day and elbow disability,
physiotherapy differed significantly over time, comparing
to injection group, for these clinical outcomes. The mean
total costs per patient for corticosteroid injections were
Euro 430, compared to Euro 631 for the wait-and-see
policy and Euro 921 for physiotherapy. These differences
were statistically significant for corticosteroid injections
compared to physiotherapy. The cost-effectiveness ratios
showed no statistically significant differences between the
three groups. The cost-utility ratio comparing physio-
therapy and wait-and-see policy was 34,461 (1,982;
9,535,522); the other cost-utility ratios were not statisti-
cally significant. CONCLUSIONS: The results of this
economic evaluation provide no reason to update or
amend the Dutch guidelines for general practitioners,
which recommend a wait-and-see policy for patients with
lateral epicondylitis.
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OBJECTIVES: To evaluate the responsiveness of the SF-
36 subscales, the generic physical (PCS) and mental
(MCS) components of the SF-36, and the SF-36 Arthritis-
Specific Health Index (ASHI) to changes in disability
measured by the Health Assessment Questionnaire
(HAQ) in RAPOLO. METHODS: We identified 388 par-
ticipants from RAPOLO, a longitudinal, observational
study of RA, who had repeated measures of arthritis spe-
cific function (HAQ and ASHI) and general function (SF-
36). We categorized patients into three groups according
to HAQ score—(1) stable, (2) declined (increase in HAQ
score of 0.25) and (3) improved (a decline in HAQ
score of 0.25). For each group we calculated Guyatt’s
statistic—a measure of responsiveness to change. The
larger the absolute value of Guyatt’s statistic, the greater
the responsiveness to change. RESULTS: Cohort is 79%
female; mean disease duration is 13.2 yrs; mean age is 55
yrs. There were 286 participants who had no change in
HAQ score. Guyatt’s statistic ranged between 0.04 to
0.17 (Social Functioning). There were 52 participants
who declined. The Guyatt’s statistics for the SF-36
ranged from 0.11 (Role Emotional) to 1.88 (Role-Physi-
cal). There were 46 participants who improved in HAQ
score. The Guyatt’s statistic ranged from 0.14 (Mental
Component Summary Score) to 1.58 (Role-Physical).
CONCLUSIONS: Statistics less than 0.3 indicate no re-
sponsiveness to change, statistics 0.5 reflect responsive-
ness to change. The physical subscales of the SF-36, the
PCS, and the ASHI were moderately to highly responsive
to change in HAQ score. The emotional subscales were
not responsive to change in disability.
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BACKGROUND: Health-related quality of life (HR-
QOL) measures have been used to study the impact of
disease activity in patients with rheumatoid arthritis
(RA). The objective of this study was to evaluate the cor-
relation between SF-36 scales, physical function (PF), role
physical (RP) and bodily pain (BP) and Rapid Assessment
of Disease Activity in Rheumatology (RADAR). METH-
